Since BDNF expression is decreased in the hippocampal and temporal lobes of patients with AD or AD model rats, measuring BDNF, TrkB, and CREB expression levels may be useful for assessing AD progression [23,24]. This evidence concerns the gene NTRK2 and Alzheimer disease.